Albert David Valuation
Is 524075 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 2/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 524075?
Other financial metrics that can be useful for relative valuation.
|What is 524075's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does 524075's PE Ratio compare to its peers?
|Company||PE||Estimated Growth||Market Cap|
531726 Panchsheel Organics
540937 Medico Remedies
540686 Smruthi Organics
540737 Shree Ganesh Remedies
524075 Albert David
Price-To-Earnings vs Peers: 524075 is good value based on its Price-To-Earnings Ratio (9.9x) compared to the peer average (41.9x).
Price to Earnings Ratio vs Industry
How does 524075's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?
Price to Earnings Ratio vs Fair Ratio
What is 524075's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||9.9x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 524075's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of 524075 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 524075 (₹589.6) is trading above our estimate of fair value (₹273.19)
Significantly Below Fair Value: 524075 is trading above our estimate of fair value.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.